vs
Side-by-side financial comparison of Sanara MedTech Inc. (SMTI) and SMITH & NEPHEW PLC (SNN). Click either name above to swap in a different company.
Sanara MedTech Inc. is a US-based medical technology company that develops, manufactures, and distributes innovative surgical, wound care, and post-acute rehabilitation products. It mainly serves healthcare providers, hospitals, and long-term care facilities across North America, with a portfolio of FDA-cleared solutions designed to improve patient outcomes and lower clinical care operational costs.
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company headquartered in Watford, England. It is an international producer of advanced wound management products, arthroscopy products, trauma and clinical therapy products, and orthopaedic reconstruction products. Its products are sold in over 100 countries. It is listed on the London Stock Exchange and is a constituent of the FTSE 100 Index.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $27.5M | — | ||
| Q3 25 | $26.3M | — | ||
| Q2 25 | $25.8M | — | ||
| Q1 25 | $23.4M | — | ||
| Q4 24 | $26.3M | — | ||
| Q3 24 | $21.7M | — | ||
| Q2 24 | $20.2M | — | ||
| Q1 24 | $18.5M | — |
| Q4 25 | $-1.6M | — | ||
| Q3 25 | $-30.4M | — | ||
| Q2 25 | $-2.0M | — | ||
| Q1 25 | $-3.5M | — | ||
| Q4 24 | $-1.7M | — | ||
| Q3 24 | $-2.9M | — | ||
| Q2 24 | $-3.5M | — | ||
| Q1 24 | $-1.8M | — |
| Q4 25 | 93.2% | — | ||
| Q3 25 | 92.9% | — | ||
| Q2 25 | 92.5% | — | ||
| Q1 25 | 92.2% | — | ||
| Q4 24 | 91.4% | — | ||
| Q3 24 | 90.8% | — | ||
| Q2 24 | 90.0% | — | ||
| Q1 24 | 89.8% | — |
| Q4 25 | 23.5% | — | ||
| Q3 25 | 11.2% | — | ||
| Q2 25 | -0.1% | — | ||
| Q1 25 | -8.9% | — | ||
| Q4 24 | 18.6% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | -14.3% | — | ||
| Q1 24 | -8.3% | — |
| Q4 25 | -5.9% | — | ||
| Q3 25 | -115.5% | — | ||
| Q2 25 | -7.8% | — | ||
| Q1 25 | -15.1% | — | ||
| Q4 24 | -6.5% | — | ||
| Q3 24 | -13.2% | — | ||
| Q2 24 | -17.4% | — | ||
| Q1 24 | -9.5% | — |
| Q4 25 | $-0.32 | — | ||
| Q3 25 | $-3.40 | — | ||
| Q2 25 | $-0.23 | — | ||
| Q1 25 | $-0.41 | — | ||
| Q4 24 | $-0.18 | — | ||
| Q3 24 | $-0.34 | — | ||
| Q2 24 | $-0.41 | — | ||
| Q1 24 | $-0.21 | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
